Mosenzon O, Wei C, Davidson J, Scirica BM, Yanuv I, Rozenberg A, et al
Summary: Results from retatrutide typically become meaningful from months 36, with Phase 2 trial data showing continued weight loss through 48 weeks at higher doses
Some people may simply experience decreased cravings, while others may experience strong food aversions, especially in the early phases of taking the medication
Peptide drugs can generate impurities through several mechanisms during manufacturing
Note: While compounded tirzepatide is often more affordable than the retail price of branded versions, it is not a generic in the traditional sense
Tirzepatide achieved up to 2022% mean weight loss at comparable timepoints in the SURMOUNT trials